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Objective: Incidence of perioperative complications is increased and outcome is poor in young patients undergoing
vascular surgery. We extensively reviewed results of lower-extremity procedures in this group of patients to further define
the extent of short-term and long-term morbidity.
Methods: Results from our vascular registry were retrospectively reviewed for 76 lower-extremity revascularization
procedures performed between January 1990 and May 2000 in 51 patients younger than 40 years. This represents 1.88%
of 4052 lower-extremity bypass procedures performed during this period. Perioperative cardiac complications, long-term
survival, graft patency, and limb salvage were evaluated. Kaplan-Meier curves were generated, and their significance was
determined with the Cox-Mantel test.
Results: Forty-nine percent of patients were male, and 51% were female; mean age at presentation was 35.9 years (range,
27.5-39.8 years). Preoperative morbidity included diabetes mellitus (96.1%), smoking (70.6%), hypertension (78.4%),
coronary artery disease (37.3%), hyperlipidemia (33.3%), and renal dysfunction (52.9%). Overall rate for 30-day
postoperative mortality was 0.0%, for myocardial infarction was 0.0%, and for congestive heart failure was 1.32%.
Thirty-day graft failure was 11.1% (n 9). At 1 year, primary patency was 71.0%, secondary patency was 82.5%, and limb
salvage was 87.1%; and at 5 years these rates were 51.9%, 63.4%, and 77.2%, respectively. After the initial surgery 11.8%
(n  6) of patients required at least one additional ipsilateral revascularization procedure, 31.3% (n  16) required a
bypass graft in the contralateral limb, and 23.5% (n  12) ultimately required amputation. In patients who required
additional ipsilateral procedures, 1-year primary patency rate was 66.7%, secondary patency rate was 62.5%, and limb
salvage rate was 77.8%, compared with 5-year rates of 44.4%, 41.7%, and 64.8%, respectively, representing a decrease in
patency compared with primary revascularization procedures. Overall survival at 1 year was 88.2%, compared with 73.3%
at 5 years. Patients with preexisting renal disease had significantly decreased survival at 5 years compared with those
without renal dysfunction (64.5% vs 82.6%; P  .019).
Conclusions: Our data suggest that age younger than 40 years is not associated with increased perioperative morbidity and
mortality. However, these patients have a significant rate of early graft failure and dismal long-term survival, especially in
patients with preexisting renal dysfunction. In addition, ipsilateral repeat operations have a marginal success rate. (J Vasc
Surg 2003;38:1056-9.)
Arterial occlusive disease in young patients is rare but
complex.1,2 The incidence of atherosclerosis in young pa-
tients ranges from 1.4% to 17%.3
Premature atherosclerosis is the most common cause of
lower-extremity ischemia in young adults.1 This form of
atherosclerosis, unlike that in elderly patients, is considered
an aggressive disease with rapid progression and poor prog-
nosis.1,4-10
The cause of premature atherosclerosis is unclear. Sev-
eral factors have been identified that may increase risk for
accelerated atherosclerosis in young patients. Smoking,
hypercoagulable states, and renal failure are considered
significant risk factors for development of the dis-
ease.1,3,5,7,9,10 In addition, patients with type I diabetes
mellitus are at increased risk for lower extremity ischemia
early in life.3,11,12 Type I diabetes is also associated with
significantly increased mortality. Data from the Joslin Dia-
betes Center demonstrate a mortality rate of 50% in pa-
tients with type I diabetes by age 54 years, and a median
25-year decrease in survival compared with the general
population.11
Controversy has surrounded lower extremity revascu-
larization in young patients.1,4,8,12 Increased perioperative
complications and poor outcome has been reported in
young patients undergoing vascular surgery.1,9,10,13,14
Levy et al1 demonstrated that in patients younger than 40
years requiring lower-extremity bypass grafting the rate of
secondary procedures was 53% and the amputation rate was
27%. The increased rate of multiple revascularization pro-
cedures and progression to amputation are consistent with
findings of other studies. Toursarkissian et al15 demon-
strated an 18-month primary patency rate of 60%  11%
and a limb salvage rate of 71%  9% in patients younger
than 50 years. In addition, 5-year mortality in these young
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patients is as high as 17% to 26%.8,9 Fewer reports have
demonstrated that there is no significant difference in out-
come for this subgroup of patients.2,3 In an attempt to
more clearly understand the outcome of surgical interven-
tion in these young patients, we report our experience with
lower-extremity revascularization in patients younger than
40 years. Almost this entire cohort of young patients un-
dergoing vascular surgery had type I diabetes mellitus.
PATIENTS AND METHODS
We reviewed data for all patients younger than 40 years
who underwent lower-extremity revascularization between
January 1990 and May 2000 at the West Campus of the
Beth Israel Deaconess Medical Center, Boston, Mass. Data
were prospectively entered into a computerized vascular
registry established in 1990. For patients with multiple
operations, risk factors and operative results were entered
into the registry for each procedure performed. Staff vascu-
lar surgeons with vascular fellows or general surgery resi-
dents performed 76 procedures in 51 patients. This repre-
sents 1.88% of 4052 lower-extremity bypass graft
operations performed during this period. Patients routinely
recovered in a vascular step-down unit before being trans-
ferred to the patient floor.
Demographic data and preoperative risk factors in our
patient population, including age, hypertension, previous
myocardial infarction, congestive heart failure, chronic re-
nal insufficiency, and diabetes mellitus, were also entered
into the registry. We do not routinely collect laboratory
data, such as homocysteine and cholesterol concentrations
or results of hypercoagulable workup studies, in our data-
base. Given our institution’s affiliation with the Joslin Di-
abetes Center, our patient population consisted almost
exclusively of patients with type I diabetes mellitus. Renal
dysfunction included patients with creatinine concentra-
tion greater than 2.0, patients receiving hemodialysis or
peritoneal dialysis, or patients who had received a kidney
transplant.
All patients underwent preoperative angiography, but
not all of data were available in the database. Intraopera-
tively, our standard is to perform continuous hand-held
Doppler scanning of the graft. Intraoperative duplex scan-
ning is not performed. Completion angiography is per-
formed sporadically, at the discretion of the surgeon. An-
gioscopy of all vein conduits is routine.
Postoperative complications, including myocardial in-
farction and congestive heart failure, were identified at
clinical assessment and entered into the registry by staff,
residents, or fellows. Routine cycling of cardiac enzymes or
postoperative electrocardiography were not performed
without clinical indication.
There is no standard protocol for graft surveillance at
our institution. Patients with subcutaneous distal grafts
undergo hand-held Doppler scanning of the graft at rou-
tine office visits. More recently, graft surveillance is being
done in more patients.
We were able to obtain the date of death for deceased
patients from the Social Security Death Index database and
data from our registry. The cause of death was not always
identified.
Statistical analysis was performed with StatView soft-
ware (Version 5.0; SAS Institute, Cary, NC). Independent
predictors of postoperative outcome were evaluated with
logistic regression analysis. Variables were considered sig-
nificant at P  .05 (Wald test) and if the 95% confidence
interval of the odds ratio did not contain the integer 1.
Survival analysis was performed with the Kaplan-Meier
method, and values were considered significant at P  .05
(Cox-Mantel log-rank test).
RESULTS
Forty-nine percent of patients were men, and 51% were
women; mean age at presentation was 35.9 years (range,
27.5-39.8 years). Preoperative demographic data (Table I)
included diabetes mellitus (96.1%), smoking (70.6%), hy-
pertension (78.4%), coronary artery disease (37.3%), hyper-
lipidemia (33.3%), and renal dysfunction (52.9%). Of pa-
tients with renal dysfunction, 9 were receiving
hemodialysis, 6 were receiving peritoneal dialysis, and 9 had
received a kidney transplant. The indications for the initial
procedure performed at our institution included tissue loss
(85.5%), rest pain (9.2%), and claudication (3.9%). Conduit
was primarily saphenous vein, with small percentages of
arm vein, composite graft, and prosthetic graft (Table II).
Table I. Clinical characteristics of patient population
Characteristic
Percent of
patients
Gender
Male 49
Female 51
Diabetes mellitus
Type I 94.1
Type II 2.0
Comorbid condition
Hypertension 78.4
Coronary artery disease 37.3
Hyperlipidemia 33.3
Cerebrovascular disease 9.8
Previous congestive heart failure 15.7
Previous myocardial infarction 21.6
Smoking (past or present) 70.6
Renal dysfunction* 52.9
Hemodialysis 17.6
Peritoneal dialysis 11.8
Hemodialysis, peritoneal dialysis, creatinine concentration 2.0.
Table II. Conduit used in revascularization procedures
Conduit %
Greater saphenous vein 87
Lesser saphenous vein 1
Arm vein 6
Composite graft 1
Prosthetic graft 5
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Inflow and outflow vessels are listed in Table III.
Overall 30-day postoperative mortality rate was 0.0%.
Thirty-day postoperative myocardial infarction rate was
0.0%, and congestive heart failure rate was 1.32%. Thirty-
day graft failure rate was 11.1% (9 of 76 patients). For
primary revascularization procedures at 1 year, overall pri-
mary patency rate was 71.0%, secondary patency rate was
82.5%, and limb salvage rate was 87.1%; and at 5 years was
51.9%, 63.4%, and 77.2%, respectively (Table IV).
After the initial surgery 11.8% of patients (6 of 51)
required at least one additional ipsilateral revascularization
procedure. For those requiring additional ipsilateral proce-
dures, at 1 year the primary patency rate was 66.7%, sec-
ondary patency rate was 62.5%, and limb salvage was
77.8%; and at 5 years was 44.4%, 41.7%, and 64.8%, respec-
tively (Table 4). Compared with primary revascularization
procedures, additional ipsilateral procedures resulted in
decreased patency and limb salvage. In addition, 31.3% of
patients (16 of 51) required a bypass graft in the contralat-
eral limb, and 23.5% of patients (12 of 51) ultimately
required amputation.
Overall survival in this cohort of patients at 1 year was
88.2%, and at 5 years was 73.3%. Patients with preexisting
renal dysfunction (27 of 51) had significantly decreased
survival at 5 years compared with those with normal renal
function (64.5% vs 82.6%; P  .019; Fig).
CONCLUSION
Our data suggest that perioperative morbidity and
mortality are not increased in patients with diabetes under-
going lower-extremity bypass grafting. In this series there
were no perioperative deaths, and overall cardiac morbidity
was 1.3%. Our patient population is notable for a high
incidence of type I diabetes. This group of patients may not
be comparable with young patients with premature athero-
sclerosis. These findings correlate with recent work from
our institution in more than 4000 patients and a study by
Kwolek et al,11 which reported on patients with juvenile-
onset diabetes mellitus who underwent revascularization.
Early (30-day) graft failure rate was 11.1%. The specific
reasons for this high rate are not clear, but it may reflect
more diffuse disease in this group, and a more aggressive
approach in younger patients. We may attempt revascular-
ization in patients with suboptimal target vessels. It is
difficult to predict in which patients revascularization will
fail, and even more difficult to perform primary amputation
in a young person without an attempt at revascularization,
even if there is risk for failure.
At follow-up we found that 11.8% of patients required
at least one additional ipsilateral revascularization proce-
dure, 31.3% required a contralateral bypass graft, and in
23.5% amputation was ultimately necessary. This is poten-
tially important information for patients without primary
saphenous vein for whom decisions regarding alternative
conduits must be made. Several investigators have found
similar decreases in patency and limb salvage.1,9,10,13,14
Toursarkissian et al15 evaluated 31 patients younger than
50 years who had diabetes and were undergoing infraingui-
nal bypass grafting for limb salvage. They also found an
acceptable rate of major complications, with comparable
limb salvage rates. Harris et al9 found that patients younger
than 50 years with peripheral vascular disease had signifi-
cantly higher rates of repeat operation, limb salvage, and
amputation. In addition, Levy et al1 reported that patients
younger than 40 years frequently had failure of primary
arterial reconstructions, need for repeat procedures, and
high amputation rates. Both of these reports demonstrated
a much lower incidence of diabetes mellitus in their popu-
lations of young patients, 35% and 25%, respectively. It is
important to differentiate young patients with diabetes
from those with premature atherosclerosis in the general
population, because of different risk factors.
Our amputation rate of 23.5% correlates with other
studies that reported amputation rates ranging from 20.7%
to 31% in patients younger than 50 years.1,4,9 One study
found this to be a threefold increase when comparing
patients younger and older than 50 years.4
Table III. Inflow and outflow vessels used in 76 procedures
Inflow vessel n % Outflow vessel n %
Femoral artery 51 67.1 Dorsalis Pedis artery 23 30.3
Below-knee popliteal artery 16 21.1 Below-knee popliteal artery 18 23.7
Above-knee popliteal artery 6 7.9 Tibial artery 14 18.4
Common iliac artery 2 2.6 Above-knee popliteal artery 9 11.8
Tibial artery 1 1.3 Other 6 7.9
Femoral artery 3 3.9
Peroneal artery 3 3.9
Table IV. Patency, limb salvage, and survival rates at 1
and 5 Years
Revascularization outcome and
overall survival 1 y 5 y
Primary procedure
Primary patency (%) 71.0 51.9
Secondary patency (%) 82.5 63.4
Limb salvage (%) 87.1 77.2
Additional ipsilateral procedures
Primary patency 66.7 44.4
Secondary patency 62.5 41.7
Limb salvage 77.8 64.8
Overall survival (%) 88.2 73.3
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In addition, ipsilateral repeat operations were fre-
quently required in these young patients. Success rate was
marginal compared with the primary procedure. Primary
patency rate, secondary patency rate, and limb salvage rate
were 66.7%, 62.5%, 77.8%, respectively, at 1 year and
44.4%, 41.7%, and 64.8%, respectively, at 5 years. The
reasons for these results, other than need for alternative
conduit, are unclear. Although some studies question the
virulence of atherosclerosis in young patients, we believe our
findings reflect rapid progression of the disease. We do not,
however, perform routine graft surveillance in our patients.
Finally, although we clearly show that these young
patients have the same rate of serious perioperative compli-
cations as our older patients do, this group had dismal
long-term survival, especially those with pre-existing renal
dysfunction. Approximately 25% of our patients younger
than 40 years did not survive 5 years. The reason for poor
long-term survival is unclear, because the cause of death
was not known for all patients. However, it can be extrap-
olated that the complications of diabetes and renal failure
may have had a significant role. This is consistent with a
previous report from our institution of 145 dialysis-depen-
dent patients with 1-year, 3-year, and 5-year survival rates
of 57%, 17%, and 4%, respectively. However, we were
unable to clearly identify specific preoperative risk factors
that were independent predictors of poor outcome, graft
patency, and limb salvage, given the small number of young
patients undergoing vascular surgery.
In conclusion, it appears that in patients with diabetes
who are younger than 40 years of age, lower-extremity
revascularization can be performed with acceptable mor-
bidity and mortality and with reasonable expectation of
limb salvage. However, the rate of early graft failure is
significant and long-term survival rate is dismal, especially
in patients with preexisting renal dysfunction. Multiple
attempts after failed primary revascularization are likely to
yield inferior results. Young patients need to be made aware
of this increased risk for poor outcome, including limb loss,
and attempts must be made to mitigate any risk factors to
aid longer survival.
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Cumulative survival (%) in patients with normal renal function
(squares) and with renal dysfunction (circles).
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